Navigation Links
ESBATech's Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications
Date:4/24/2008

ogy platform for therapeutic antibody fragments, we started preclinical development of ESBA105 in mid 2006. Now to move this swiftly into the clinic is a truly exciting time for the company. ESBA105 represents a new generation of antibody fragment therapeutics that have favourable biochemical properties over earlier classes of antibody fragments, such as high stability, solubility and high monomeric content. This allows us to deliver the drug topically, without any need to stabilize or modify the protein. Thanks to the small protein size as compared to conventional antibodies, ESBA105 efficiently penetrates into all segments of the eye, which results in a high local concentration where the drug is needed to inhibit inflammation. As this is associated with low systemic drug exposure, this novel therapeutic approach has a very low risk of provoking systemic adverse effects."

ESBATech is the first and only company to date that has successfully screened and characterized the entire human pool (1.5 million) of naturally occurring variable immunoglobulin (VH and VL) domains to select highly stable, soluble and monomeric single-chain antibody fragments frameworks. The company is advancing a pipeline of novel, antibody fragment therapeutics for topical and/or local delivery, to ensure safe and convenient patient therapy.

About ESBATech AG

ESBATech AG is a Zurich, Switzerland-based, privately held drug discovery and development company focused on advancing antibody fragments for therapeutic applications. The company applies its proprietary, fully human single-chain antibody frameworks to generate product candidates against targets of clinical relevance. ESBATech is focused on delivering high concentrations of its therapeutic antibody fragments to the targeted sites, in combination with extremely low systemic load, in order to achieve low risk of systemic drug reactions using topical and local delivery. Current venture investors include SV Life Sciences,
'/>"/>

SOURCE ESBATech AG
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
2. MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13
3. OncoMed Chooses SynCo Bio Partners to Fill and Finish its Lead Antibody
4. Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study
5. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
6. MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma
7. Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research
8. Raven Announces Completion of Enrollment in the Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for the Treatment of Adenocarcinomas
9. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
10. Celltrion and CSL Announce Collaboration to Develop and Manufacture Monoclonal Antibody
11. Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... -- - CPhI and P-MEC China 2015 ... Shanghai, China - The 15th ... held at Shanghai New International Expo Center, on 24th June, ... Worldwide and was introduced to China in 2001. It has ... companies and global pharmaceutical industry over the past 15 years. ...
(Date:3/3/2015)... -- Tru-D SmartUVC will exhibit the cutting-edge UV disinfection ... Surgical Conference and Expo 2015 in ... Week March 7 through 11. AORN provides perioperative ... professional development. Photo - ... Tru-D SmartUVC,s UV light disinfection ...
(Date:3/3/2015)... -- Depomed, Inc. (NASDAQ: DEPO ) today announced ... Annual Roth Conference in Laguna Niguel , ... am PT) Tuesday, March 10, 2015. The presentation ... the Investor Relations page of the Depomed website at ... for 30 days on the company,s website. ...
Breaking Medicine Technology:15th Anniversary, Be Part of Chinese Pharma Dream 215th Anniversary, Be Part of Chinese Pharma Dream 3Tru-D SmartUVC to Exhibit Most Effective UV Disinfection Robot at AORN Surgical Conference and Expo 2015 2Tru-D SmartUVC to Exhibit Most Effective UV Disinfection Robot at AORN Surgical Conference and Expo 2015 3Depomed To Present At 27th Annual Roth Conference 2
... A new study in the journal Cancer shows that staging ... prostate gland does predict the outcome, prognosis or risk of ... many prostate cancer treatment surgeons have thought about ... – something I strongly disagree with," said Dr. David ...
... Dec. 14, 2010   Reportlinker.com announces that a ... catalogue: European Markets for Video, ... http://www.reportlinker.com/p0339834/European-Markets-for-Video-High-Tech-and-Integrated-OT-Equipment-2011.html The ... Theatre (OT) Equipment 2011 includes Austria, Benelux, France, ...
Cached Medicine Technology:Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Staging and Prostate Cancer Recurrence Study 2Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Staging and Prostate Cancer Recurrence Study 3Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 2Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 3Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 4Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 5Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 6Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 7Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 8Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 9Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 10Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 11Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 12Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 13Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 14Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 15Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 16Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 17Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 18Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011 19
(Date:3/3/2015)... State after state prove the cost ... programs aimed to rehabilitate nonviolent drug offenders. The ... of incarcerating violators of drug laws, as opposed ... treatment. Governor Bruce Rauner ( R)has proposed to ... and alcohol statewide Department of Alcoholism and Substance ...
(Date:3/3/2015)... Raritan Bay Medical Center is proud to ... photo contest held at the Woodbridge Center Mall in ... awareness for health and wellness in the Central New ... health and wellness tips. , Photos of visitors sharing ... and Facebook page where Facebook users voted on their ...
(Date:3/3/2015)... RI (PRWEB) March 03, 2015 ... announced the Department of Veterans Affairs has signed a ... effective March 1, 2015. , Under the contract, ... agencies such as the U.S. Military, Indian Health Services, ... and local government entities with competitive pricing for hospital ...
(Date:3/3/2015)... A newly launched program is available for the ... and pre-diabetes. As opposed to traditional pharmaceutical methods, Reverse ... sufferers to reverse their disease without the use of ... the U.S. diabetes industry made $250 billion from the ... use of insulin and other glucose-controlling medications that act ...
(Date:3/3/2015)... March 03, 2015 T-System Inc. ... BSN, MBA, CEN, CPHQ, FABC as the company’s chief ... innovation for unscheduled, episodic care. , “Today’s ... episodic care settings including urgent care and freestanding emergency ... healthcare,” said Roger Davis, T-System’s chief executive officer. ...
Breaking Medicine News(10 mins):Health News:Gov. of Illinois, Bruce Rauner, Suggests Cutting 25 Million for Drug Rehabilitation, Harbor Village Comments 2Health News:Raritan Bay Medical Center Announces Winners of “Picture of Health” Photo Contest 2Health News:Claflin Medical Equipment (CME) Announces New 5 Year Contract with the Department of Veterans Affairs (VA) 2Health News:New Breakthrough In Diabetes Reaserch Show Scientifically Proven Way To Reverse Your Diabetes Naturally In 30 Short Days 2Health News:T-System Renews Commitment to Clinically-Driven Innovation and Appoints Industry Leader as CNO 2Health News:T-System Renews Commitment to Clinically-Driven Innovation and Appoints Industry Leader as CNO 3
... , Republican Congressman Slated to Oppose President ... and Insurance Campaign Contributions , , WASHINGTON, ... interest questions about Rep. Charles Boustany (R-La.) and the expected opposing ... speech to a joint session of Congress on health care reform. ...
... KALAMAZOO, Mich., Sept. 9 Stryker Corporation (NYSE: ... call on Tuesday, October 20, 2009, at 4:30 p.m., Eastern Time, ... 30, 2009, and provide an operational update. Operating results for the ... that day. , , To participate in the ...
... , KEYSTONE TREATMENT AND OUTREACH CENTER, 7511 ... TO FOLLOW AT CANTON AT 1 PM: , KEYSTONE TREATMENT CENTER, ... at both locations , , SIOUX FALLS and CANTON, ... will be the 2009 national headquarters at 11 AM Wednesday, September 16, to ...
... , WASHINGTON, Sept. 9 On Thursday, ... legislative lobbying arm of Family Research Council, will host a special ... President Tony Perkins will be joined by Congressional leaders and policy experts ... care plan. , , Webcast viewers will ...
... , GORDONSVILLE, Va., Sept. 9 PBM ... Beginnings(R) NeoCare(TM) Weight Gain Infant Formula. Comparable to Similac(R) NeoSure(R), ... meet the nutritional needs of low birth weight infants (LBW) ... suggests that catch-up growth increases when feeding infants nutrient-enriched formulas ...
... prevent sudden cardiac death, researchers recommend electrocardiograms , WEDNESDAY, ... tested for heart abnormalities to prevent sudden cardiac death ... Sudden cardiac death is the leading cause of death ... it is, as figures vary and mandatory reporting does ...
Cached Medicine News:Health News:Rep. Boustany Hauled in $1.25 Million From Health and Insurance Industry 2Health News:Stryker To Host Conference Call on October 20, 2009 2Health News:Wed., Sept. 16, 11 AM News Conference: Sioux Falls' Keystone Treatment Center Is National HQ to Lead 100 Locations Nationwide in Balloon Liftoff Celebrating Recovery Against New Wave of Drug Abuse; Former U.S. Drug Czar/4-Star Gen. Barry McCaffrey, Lieute 2Health News:Bright Beginnings(R) NeoCare(TM) Value-Priced Weight Gain Infant Formula Now Available Online at www.pbmstore.com 2Health News:Testing Young Athletes for Heart Defects May Save Lives 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: